Facing rising labor costs, payer compression, and administrative drag, GI Partners of Illinois is rejecting the idea that margin erosion…
Browsing: Business
CONMED Corporation announced plans to exit its gastroenterology product lines, accelerating a strategic shift toward its core markets in minimally…
Liquid biopsy developer Freenome is heading to the public markets via a $330M SPAC merger with Perceptive Capital Solutions, securing…
The Gastro Center of Maryland, one of the largest GI practices in the state, has opened two new locations —…
Three powerhouse GI platforms continue to dominate physician-practice acquisitions and ASC expansion nationwide: GI Alliance (TX) ~1,000 physicians | 400+…
Abbott has announced a $23B deal to acquire Exact Sciences, maker of the leading at-home colorectal cancer test used more…
Roche is moving aggressively into multi-cancer screening outside the U.S. with a new deal to commercialize Freenome’s kitted blood-based CRC…
A major infusion-care shakeup is underway. Shore Capital Partners has merged Reliant Healthcare and Care Fusion Rx to create a…
Medicare just rewrote the telehealth rulebook for 2026. The new funding bill and final Physician Fee Schedule lock in some…
Three Takeaways for the Future of GI 1. Cancer Screening Enters a New Scale PhaseAbbott’s acquisition signals a structural shift:…